Cleveland BioLabs Cash from Financing Quarterly:
15.66M for Dec. 31, 2012Cleveland BioLabs Historical Cash from Financing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 15.66M |
| Sept. 30, 2012 | -0.0158M |
| June 30, 2012 | 5.878M |
| March 31, 2012 | -0.0035M |
| Dec. 31, 2011 | 9.005M |
| Sept. 30, 2011 | 0.0049M |
| June 30, 2011 | 22.25M |
| March 31, 2011 | 3.508M |
| Dec. 31, 2010 | 8.696M |
| Sept. 30, 2010 | 0.1644M |
| June 30, 2010 | 3.613M |
| March 31, 2010 | 4.591M |
| Dec. 31, 2009 | 0.1914M |
| Sept. 30, 2009 | 0.1091M |
| June 30, 2009 | 0.083M |
| March 31, 2009 | 3.898M |
| Dec. 31, 2008 | -0.0068M |
| Sept. 30, 2008 | -0.5582M |
| June 30, 2008 | -0.0073M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
About Cash From Financing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More
CBLI Cash from Financing Quarterly Benchmarks
| Companies | |
|---|---|
| Athersys | 21.31M |
| Osiris Therapeutics | 0.158M |
| Transcept Pharmaceuticals | 0.232M |
CBLI Cash from Financing Quarterly Rankings
| Overall |
91st percentile 717 of 8007 |
| Sector |
89th percentile 71 of 685 in Healthcare |
| Industry |
87th percentile 30 of 248 in Biotechnology |
CBLI Cash from Financing Quarterly Range, Past 5 Years
| Minimum | -0.5582M | Sep 2008 |
| Maximum | 22.25M | Jun 2011 |
| Average | 4.056M |
